Zobrazeno 1 - 3
of 3
pro vyhledávání: '"William M. Kohlbrenner"'
Autor:
J Song, Xiaoyu Lin, William M. Kohlbrenner, S W Fesik, Rongqi Wang, X Zhao, Leiming Li, Y Shen, Denise Wilcox
Publikováno v:
Gene Therapy
Delivering small interfering RNA (siRNA) to tumors using clinically viable formulations remains the primary technical hurdle that prevents the development of siRNA therapy for cancer treatment. Over the past several years, significant effort has been
Autor:
Carol K. Wada, Prasad A. Dande, Xiaoyu Lin, William M. Kohlbrenner, Lu Tian, Stephen W. Fesik, Robert D. Hubbard, Xiaoli Huang, Denise Wilcox, Aparna Sarthy, Xiaobin Zhao, Yu Shen, Leiming Li, Todd M. Hansen, Rongqi Wang
Publikováno v:
Molecular cancer therapeutics. 12(11)
Successful siRNA therapeutics requires the optimal integration of multiple components, including an efficient delivery system, a disease indication that is appropriate for siRNA-based therapy, and a potent and nontoxic siRNA against a robust therapeu
Autor:
Liqing Chen, Wlodek Mandecki, Cele Abad-Zapatero, Janusz M. Sowadski, Sean M. Bell, William M. Kohlbrenner, David J. Neidhart
Publikováno v:
"Protein Engineering, Design and Selection". 5:605-610
Mutagenesis of the absolutely conserved residue Asp101 of the non-specific monoesterase alkaline phosphatase (E.C. 3.1.3.1) from E. coli has produced an enzyme with increased kcat. The carboxyl group of the Asp101 residue has been proposed to be invo